FOLH1 and cancer: Analysing only diseases with strong neovascular PSMA expression (labelling index 2), malignant tumors presenting with a high PSMA expression were more frequent (19/63; 30.2%) compared to benign diseases (1/38; 2.63%) (p = 0.0006, Fisher ́s exact test).